BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 31385458)

  • 1. PTTG1 is involved in TNF-α-related hepatocellular carcinoma via the induction of c-myc.
    Lin X; Yang Y; Guo Y; Liu H; Jiang J; Zheng F; Wu B
    Cancer Med; 2019 Sep; 8(12):5702-5715. PubMed ID: 31385458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma.
    Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q
    Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the pituitary tumor transforming gene 1 in the progression of hepatocellular carcinoma.
    Liang M; Chen X; Liu W; Li S; Li C; Jiang L; Lv S
    Cancer Biol Ther; 2011 Feb; 11(3):337-45. PubMed ID: 21099350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Aconitum coreanum polysaccharide fraction induces apoptosis of hepatocellular carcinoma (HCC) cells via pituitary tumor transforming gene 1 (PTTG1)-mediated suppression of the P13K/Akt and activation of p38 MAPK signaling pathway and displays antitumor activity in vivo.
    Liang M; Liu J; Ji H; Chen M; Zhao Y; Li S; Zhang X; Li J
    Tumour Biol; 2015 Sep; 36(9):7085-91. PubMed ID: 25874498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis.
    Fujii T; Nomoto S; Koshikawa K; Yatabe Y; Teshigawara O; Mori T; Inoue S; Takeda S; Nakao A
    Hepatology; 2006 Jun; 43(6):1267-75. PubMed ID: 16628605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of FEN1 Is Associated with the Tumor Progression and Prognosis of Hepatocellular Carcinoma.
    Zhang Y; Liu X; Liu L; Chen J; Hu Q; Shen S; Zhou Y; Chen S; Xue C; Cui G; Yu Z
    Dis Markers; 2020; 2020():2514090. PubMed ID: 32399086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYLD controls c-MYC expression through the JNK-dependent signaling pathway in hepatocellular carcinoma.
    Pannem RR; Dorn C; Ahlqvist K; Bosserhoff AK; Hellerbrand C; Massoumi R
    Carcinogenesis; 2014 Feb; 35(2):461-8. PubMed ID: 24104553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant Expression of CCAT1 Regulated by c-Myc Predicts the Prognosis of Hepatocellular Carcinoma.
    Zhu HQ; Zhou X; Chang H; Li HG; Liu FF; Ma CQ; Lu J
    Asian Pac J Cancer Prev; 2015; 16(13):5181-5. PubMed ID: 26225650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of MEK suppresses hepatocellular carcinoma growth through independent MYC and BIM regulation.
    Zhou X; Zhu A; Gu X; Xie G
    Cell Oncol (Dordr); 2019 Jun; 42(3):369-380. PubMed ID: 30788663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fanconi Anemia Complementation Group E, a DNA Repair-Related Gene, Is a Potential Marker of Poor Prognosis in Hepatocellular Carcinoma.
    Takahashi J; Masuda T; Kitagawa A; Tobo T; Nakano Y; Abe T; Ando Y; Kosai K; Kobayashi Y; Matsumoto Y; Yoshizumi T; Mori M; Mimori K
    Oncology; 2022; 100(2):101-113. PubMed ID: 34724663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR‑374c‑5p regulates PTTG1 and inhibits cell growth and metastasis in hepatocellular carcinoma by regulating epithelial‑mesenchymal transition.
    Yang G; Xiog Y; Wang G; Li W; Tang T; Sun J; Li J
    Mol Med Rep; 2022 Apr; 25(4):. PubMed ID: 35234260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABL1, Overexpressed in Hepatocellular Carcinomas, Regulates Expression of NOTCH1 and Promotes Development of Liver Tumors in Mice.
    Wang F; Hou W; Chitsike L; Xu Y; Bettler C; Perera A; Bank T; Cotler SJ; Dhanarajan A; Denning MF; Ding X; Breslin P; Qiang W; Li J; Koleske AJ; Qiu W
    Gastroenterology; 2020 Jul; 159(1):289-305.e16. PubMed ID: 32171747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFITM3 upregulates c-myc expression to promote hepatocellular carcinoma proliferation via the ERK1/2 signalling pathway.
    Min J; Hu J; Luo C; Zhu J; Zhao J; Zhu Z; Wu L; Yuan R
    Biosci Trends; 2020 Jan; 13(6):523-529. PubMed ID: 31852866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A c-Myc/miR-17-5p feedback loop regulates metastasis and invasion of hepatocellular carcinoma.
    Liu D; Dong L; Liu Y; Wen D; Gao D; Sun H; Fan J; Wu W
    Tumour Biol; 2016 Apr; 37(4):5039-47. PubMed ID: 26546431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid Receptor Coactivator 1 Promotes Human Hepatocellular Carcinoma Progression by Enhancing Wnt/β-Catenin Signaling.
    Tong Z; Li M; Wang W; Mo P; Yu L; Liu K; Ren W; Li W; Zhang H; Xu J; Yu C
    J Biol Chem; 2015 Jul; 290(30):18596-608. PubMed ID: 26082485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of GNMT by 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranoside through proteasome-independent MYC downregulation in hepatocellular carcinoma.
    Kant R; Yen CH; Hung JH; Lu CK; Tung CY; Chang PC; Chen YH; Tyan YC; Chen YA
    Sci Rep; 2019 Feb; 9(1):1968. PubMed ID: 30760754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eukaryotic Initiation Factor 5A2 Contributes to the Maintenance of CD133(+) Hepatocellular Carcinoma Cells via the c-Myc/microRNA-29b Axis.
    Bai HY; Liao YJ; Cai MY; Ma NF; Zhang Q; Chen JW; Zhang JX; Wang FW; Wang CY; Chen WH; Jin XH; Xu RH; Guan XY; Xie D
    Stem Cells; 2018 Feb; 36(2):180-191. PubMed ID: 29119708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.